May 05, 2020
Unprecedented 3-Year Safety Data Unveiled At Digestive Disease Week (DDW) Indicates No Pattern Of Heartburn With IBgard®, An Advanced Technology Peppermint Oil, Contrary To Heartburn Issues With Older Technologies
Apr 13, 2020
EmeTerm, by WAT Medical, an easy solution for Cyber Sickness
Apr 01, 2020
For IBS Awareness Month, a free trial offer to help improve IBS symptoms
Mar 23, 2020
Brazil Enteral Nutrition Market to Surpass US$ 460.8 Million by 2027, at a CAGR of 4.5% - Coherent Market Insights
Mar 09, 2020
The irritable bowel syndrome treatment market was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026
Mar 09, 2020
In A Peer-Reviewed Article In A Leading Gastroenterology Journal, Nonprescription FDgard® Is Added To Treatment Algorithm For The Management Of Functional Dyspepsia (FD)
Mar 09, 2020
Canadians suffering from diarrhea-predominant Irritable Bowel Syndrome (IBS-D) have a new clinically proven option approved by Health Canada
Feb 17, 2020
Irritable Bowel Syndrome Treatment Market to Reach $2.01 Bn, Globally, by 2026 at 8.2% CAGR, Says Allied Market Research
Feb 12, 2020
Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes
Jan 27, 2020
Irritable Bowel Syndrome (IBS) Product Earns Top Spot from TopConsumerReviews.com
Sep 30, 2019
Immunic, Inc. to Participate in Investor and Scientific Conferences in October
Aug 07, 2019
In the Longest-Ever String of Yearly Surveys on Gastroenterologists' Preferences for Recommending Products for IBS, IBgard Continues to Widen its Already Pre-Eminent "#1 Recommended"(1) Status
Aug 07, 2019
First-Ever 36 Month Real-World, Post-Marketing Surveillance Study Confirms The Excellent Safety And Tolerability Profile Of IBgard®, A Non-Prescription Product For IBS
Jul 31, 2019
Gastric Electric Stimulators Market to Reach a 6.4% of CAGR by 2026 - PMR
Jul 29, 2019
Soligenix Receives European Patents for Oral BDP in the Treatment of Acute Radiation Injury of the Gastrointestinal Tract
Jul 09, 2019
Mirum Pharmaceuticals Initiates Phase 3 Clinical Trial for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
Jun 04, 2019
Gastric Electrical Stimulator Market - In-depth Analysis, Revealing Key Drivers & Growth Trends Through 2022: Radiant Insights, Inc
May 17, 2019
U.S. FDA Approves GATTEX® (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
May 17, 2019
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis
May 16, 2019
Bright.md launches new virtual care module to help treat Gastroesophageal Reflux Disease